Dermatitis (Eczema) Support Protocol
Primary Stack
Core supplements with strongest evidenceMay help modulate immune response; evidence for prevention and treatment
Supporting Studies (1)
Supports skin barrier function and immune modulation; deficiency linked to eczema severity
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsGLA may help skin barrier function; mixed evidence
Supporting Studies (1)
Anti-inflammatory; supports skin health
Supporting Studies (1)
Supports skin healing and immune function
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Dermatitis (eczema) is an inflammatory skin condition causing red, itchy, dry skin. Atopic dermatitis is the most common type and often runs in families with allergies and asthma.
TYPES:
SYMPTOMS:
MANAGEMENT:
* Probiotics may help, especially in children.
* Vitamin D deficiency is linked to severity.
* Moisturizing is cornerstone of treatment.
Expected timeline: Supplements may take 2-3 months to show benefit. Consistent moisturizing provides ongoing protection.
Clinical Perspective
Dermatitis/Eczema: Atopic dermatitis most common; skin barrier dysfunction + immune dysregulation. Associated with atopic triad (eczema, asthma, allergic rhinitis). Treatment: emollients (cornerstone), topical corticosteroids, TCIs. Severe: dupilumab, JAK inhibitors.
Supplements: Probiotics have best evidence (prevention and treatment in children). Vitamin D if deficient (common in eczema). EPO/fish oil have mixed evidence. Main focus: skin barrier repair with emollients, trigger avoidance, appropriate medical therapy.
* Probiotics (B-grade): Immune modulation. Cochrane: (PMID: 24045160). 10-20B CFU daily.
* Vitamin D (B-grade): Barrier/immune. Meta-analysis: (PMID: 28750270). 2000-4000 IU daily.
* Evening Primrose (C-grade): GLA. Systematic review: (PMID: 23075608). 3-6g daily.
* Omega-3 (C-grade): Anti-inflammatory. Review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Zinc (C-grade): Skin healing. Systematic review: (PMID: 26845419). 15-30mg daily.
Protocol notes: Emollients: apply liberally, frequently; ceramide-containing preferred. Steroids: appropriate potency for location; step-down approach. TCIs: tacrolimus, pimecrolimus for face, maintenance. Dupilumab: for moderate-severe; excellent efficacy. Trigger identification: consider patch testing for contact component. Infection: S. aureus colonization common; bleach baths may help. Itch-scratch cycle: break with adequate treatment.